ALWIS attended the 3rd America Drug Safety & AI Conference 2025 – Dec. 9-10, 2025 in San Diego, where our founder, Mr Abdul Rahim presented on key considerations for qualifying AI solutions in Pharmacovigilance. The session highlighted the challenges AI systems pose in life science including pharmacovigilance environments and discussed [...]
ALWIS had a rewarding presence at SCRMP Nexus 2025, where our founder, Mr. Abdul Rahim spoke on the real-world challenges of literature monitoring in pharmacovigilance. The session focused on practical difficulties faced across global and local literature sources, the limitations of automation, and realistic workarounds that help teams balance efficiency [...]
ALWIS will be present at the World Drug Safety Congress Americas 2025, held in Boston from November 4–6, bringing real-time insights into how AI and intelligent automation are reshaping pharmacovigilance. At our booth, attendees can explore our flagship pharmacovigilance solutions, see live product capabilities in action, and gain practical perspectives [...]
ALWIS is participating as a Gold Sponsor at the World Drug Safety Congress Europe 2025 in Amsterdam, engaging with the global drug safety community on the evolving role of technology in pharmacovigilance. You’ll find us at Booth 73, where our team will share practical insights into how AI-driven automation and [...]